ArticleTrader.com
  

 Main Menu

  Home
  Member Login
  Forum
  Submit Article
  RSS Feeds
  Contact Us
  About

 Services

  Article Distribution
  Link Building

 Tools

  ArticleMS
  Directory Tracker
  Earn with your Site

 Categories

  Automotive
  Business
  Computers
  Entertainment
  Finance
  Food
  Health
  » Acne
  » Alternative
  » Beauty
  » Cancer
  » Dental
  » Depression
  » Diabetes
  » Fitness
  » Lifestyle
  » Medicine
  » Men
  » Nutrition
  » Sleep
  » Stress
  » Supplements
  » Vision
  » Weight Loss
  » Women
  Home and Family
  Internet
  Legal
  Science
  Self Improvement
  Shopping
  Society
  Sports
  Technology
  Travel
  Writing

34 users online.



 
  » Category Sponsors
  Get Your Link Here - Limited Time Bargain at only $11/month!

Home » Health » Depression » Those black box warnings on antidepressants
0
Votes
Vote Now
Article Stats:
Total views: 9
Word Count: 639
Character Count: 4154
Options:
Get Html Code
Get PDF
Print View

Those black box warnings on antidepressants

Submitted by JohnScott

In both medical and legal circles, there is a constant question. How do you warn the general population of the possible dangers of taking medications. Recently, this question has become more pointed. Pressure groups now actively campaign to persuade regulatory authorities to clarify the warnings, while lawyers ask the courts to allow litigation against the manufacturers for their failures to disclose all their research information about the possible side effects.

At its heart lie two deceptively simple questions:

• do we want patients to make an informed choice about their treatment?

• if so, are they not entitled to complete information?

The answers, of course, are an equally simple "yes". But this is meaningless unless we identify what information is relevant. As an example, the risk of suicide has been associated with those who take antidepressants such as zoloft — the most prescribed antidepressant in the United States in 2007. The Food and Drug Administration requires zoloft to carry a black box warning. What should this warning say to the several million people who take it?

By its nature, zoloft is always going to have some association with suicide. Zoloft is, after all, used to treat clinical depression and some who are depressed think about death and ultimately commit suicide. Thus, we need to disentangle cause and effect. Simply saying zoloft is associated with suicide is unhelpful. We need answers to more simple questions. Let us assume that people who are depressed tend to think about suicide, so:

• does zoloft contribute to this tendency?
• does zoloft make it more likely that someone will commit suicide?

• does zoloft affect one group of people more than others?

The answer to the third question seems to be that zoloft affects the young more than the old. But this needs explanation. Consider the research into suicide and the internet published in the April edition of the British Medical Journal. There is already clear evidence that when television news covers a suicide or a drama depicts suicide, there are copycat deaths. The BMJ research tested whether there is a link between the internet and real world deaths. The internet through the search engines and sites such as wikipedia is increasingly influential. Graphic descriptions of the most reliable methods of suicide are freely available. But it is the proactive role of forums and chat rooms that represents a more potent threat. Here suicide can be encouraged as a problem-solving method and suicide pacts are agreed. This produces peer pressure, particularly among the young, to consider or attempt suicide.

How could we get more evidence? When someone commits suicide, the police and coroners could systematically record the use of zoloft, the dosage, the method of suicide, the use of the internet, searches made, forums used, and so on. When we have the evidence, all the relevant causes and their effects would become clear. As it is, the FDA has warned young people not to use zoloft. But it is probably only coincidence that young people use the internet more often and are more easily manipulated by those met in chat rooms. Without proper research, the current warnings are vague and not a rational way of regulating the use of zoloft.

People should be given all relevant information so they can make an informed decision about whether to use zoloft. Suppose someone is already subject to peer pressure from internet use and Googles methods of suicide. Why not take zoloft? Zoloft is designed to reduce depression, so this should reduce the risk of suicide.

As it stands, the warning system does not work and there is no co-ordinated research program to collect information to help it work more efficiently. Obviously, such research does not suit the commercial interests of the pharmaceutical companies because it might prove their product is not safe. It is sad that governments seem to take the manufacturers’ side rather than protect the ordinary citizen.

About the Author

Learn more about the information you read here on zoloft and by John Scott at http://www.forgetdepression.com.


Source: ArticleTrader.com

Comments

There are no comments for this article, you can be the first to post a comment.

You must be logged in to comment.
Login Now or
Register Free Account

 Top Authors

 1 alien82 (2335)
 2 juliet (1495)
 3 sverdlow (1412)
 4 limalan88 (1065)
 5 AnthonyF (1055)
 6 IC (935)
 7 cdmohatta (767)
 8 isolvum (723)
 9 lets_j2top@ya.. (657)
 10 jkhbraveheart (620)
 11 prabakar (575)
 12 jarnold (567)
 13 homebizbuilder (500)
 14 cj (484)
 15 reedstickets (461)
  » Member List

 Latest Forum

» Settings Section - Minimum Length is Available, Maximum?
» Subject3
» Forum integrated with AMS
» When is new version coming out
» Featured article
» E-mail Verification - Is it in the next version?

 Sponsors

Advertise Here
Busby SEO Challenge
Boulder homes for sale
Commercial Water Removal
Green Organic Articles
Phone cards
link Directory
powerball numbers
mold remediation


  
  Affiliate Program 2Checkout.com, Inc. is an authorized retailer of ArticleTrader.com

0.24s